Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-07

Clinical Trial Update: Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating injection techniques of collagenase clostridium histolyticum for treatment of edematous skin (cellulite).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • collagenase clostridium histolyticum (collagenase clostridium histolyticum)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Edematous Skin | Phase 2 | Status: COMPLETED | Results posted: 2023-09-07